Myriad Genetics
MYGN
#6699
Rank
A$1.00 B
Marketcap
A$10.73
Share price
-3.27%
Change (1 day)
-57.69%
Change (1 year)

Myriad Genetics (MYGN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$0.53 Billion

According to Myriad Genetics's latest financial reports the company's total liabilities are A$0.53 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Myriad Genetics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$0.52 B-1.56%
2023-12-31A$0.53 B15.97%
2022-12-31A$0.45 B-5.54%
2021-12-31A$0.48 B
2020-06-30A$0.70 B4.46%
2019-06-30A$0.67 B138.73%
2018-06-30A$0.28 B-50.79%
2017-06-30A$0.57 B223.08%
2016-06-30A$0.17 B31.37%
2015-06-30A$0.13 B21.74%
2014-06-30A$0.11 B34.87%
2013-06-30A$82.4 M53.53%
2012-06-30A$53.67 M30.64%
2011-06-30A$41.08 M-4.04%
2010-06-30A$42.81 M7.67%
2009-06-30A$39.76 M-48.39%
2008-06-30A$77.04 M85.46%
2007-06-30A$41.54 M14.57%
2006-06-30A$36.26 M18.83%
2005-06-30A$30.51 M39.76%
2004-06-30A$21.83 M-24.59%
2003-06-30A$28.95 M-43.01%
2002-06-30A$50.8 M-20.2%
2001-06-30A$63.67 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Bio-Rad Laboratories
BIO
A$4.47 B 732.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
A$5.14 B 856.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
A$33.01 M-93.86%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$2.35 B 338.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$49.82 B 9,164.57%๐Ÿ‡บ๐Ÿ‡ธ USA